Cumberland Pharmaceuticals Inc. (CPIX) vs Foghorn Therapeutics Inc. (FHTX)
A side-by-side comparison of Cumberland Pharmaceuticals Inc. and Foghorn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CPIX
Cumberland Pharmaceuticals Inc.
$7.17HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
FHTX
Foghorn Therapeutics Inc.
$1.91HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — CPIX vs FHTX
growth of $100 · dividends reinvested · last 6yCPIX +185.7% (+19.1%/yr)FHTX -89.0% (-30.7%/yr)CPIX compounded faster over this window
Log scale — wide-divergence pair
CPIX FHTX
CPIX vs FHTX: by the numbers
- •FHTX is the larger company ($112M vs $107M market cap).
- •Both run net losses; CPIX's is the smaller (-33.92% vs -175.78% net margin).
- •FHTX grew revenue faster over the past five years (105.83% vs 3.53% CAGR).
- •CPIX pays a dividend (21.16% yield), while FHTX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CPIX | FHTX |
|---|---|---|
| P/S ratio | 3.44 | 3.05 |
| P/B ratio | 6.16 | N/A |
Profitability
| Metric | CPIX | FHTX |
|---|---|---|
| Gross margin | 83.37% | 89.22% |
| Operating margin | -6.27% | -265.64% |
| Net margin | -33.92% | -175.78% |
| ROE | -60.82% | N/A |
| ROIC | -34.77% | -44.81% |
Dividends
| Metric | CPIX | FHTX |
|---|---|---|
| Dividend yield | 21.16% | N/A |
Growth (annualized)
| Metric | CPIX | FHTX |
|---|---|---|
| Revenue CAGR (5Y) | 3.53% | 105.83% |
| Total return CAGR (5Y) | 25.62% | -31.87% |
Frequently asked
- Which has grown faster, CPIX or FHTX?
- Over the past five years, FHTX grew revenue faster — CPIX at a 3.53% CAGR versus FHTX at 105.83%.
- Does CPIX or FHTX pay a bigger dividend?
- CPIX pays a dividend (21.16% yield), while FHTX has no payments in the available dividend history.
- How have CPIX and FHTX total returns compared?
- Over the past 5 years, CPIX delivered 25.62% and FHTX delivered -31.87% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cumberland Pharmaceuticals dividend yieldCumberland Pharmaceuticals ROEFoghorn Therapeutics ROECumberland Pharmaceuticals operating marginFoghorn Therapeutics operating marginCumberland Pharmaceuticals revenue growthFoghorn Therapeutics revenue growthCumberland Pharmaceuticals free cash flowFoghorn Therapeutics free cash flow
Cumberland Pharmaceuticals & Foghorn Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.